Literature DB >> 19665424

Spectral characteristics of tramadol in different solvents and beta-cyclodextrin.

A Anton Smith1, R Manavalan, K Kannan, N Rajendiran.   

Abstract

Effect of solvents and beta-cyclodextrin on the absorption and fluorescence spectra of tramadol drug has been investigated and compared with anisole. The solid inclusion complex of tramadol with beta-CD is investigated by FT-IR, (1)H NMR, scanning electron microscope (SEM), DSC and semiempirical methods. The thermodynamic parameter (DeltaG) of inclusion process is determined. A solvent study shows (i) the spectral behaviour of both tramadol and anisole molecules is similar to each other and (ii) the cyclohexanol group in tramadol is not effectively conjugated with anisole group. However, in beta-CD, due to space restriction of the CD cavity, a weak interaction is present between the above groups in tramadol. beta-Cyclodextrin studies show that tramadol forms 1:2 inclusion complex with beta-CD. A mechanism is proposed for the inclusion process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665424     DOI: 10.1016/j.saa.2009.06.047

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  3 in total

1.  Novel 1-indanone Thiosemicarbazone Antiviral Candidates: Aqueous Solubilization and Physical Stabilization by Means of Cyclodextrins.

Authors:  Romina J Glisoni; Diego A Chiappetta; Albertina G Moglioni; Alejandro Sosnik
Journal:  Pharm Res       Date:  2011-10-06       Impact factor: 4.200

2.  Encapsulation of labetalol, pseudoephedrine in β-cyclodextrin cavity: spectral and molecular modeling studies.

Authors:  A Antony Muthu Prabhu; N Rajendiran
Journal:  J Fluoresc       Date:  2012-07-01       Impact factor: 2.217

3.  Cyclodextrin Complex Formation with Water-Soluble Drugs: Conclusions from Isothermal Titration Calorimetry and Molecular Modeling.

Authors:  Karim S Shalaby; Muhammad I Ismail; Alf Lamprecht
Journal:  AAPS PharmSciTech       Date:  2021-08-31       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.